trial Janssen Pharmaceutical
Janssen ends CREDENCE trial early after meeting efficacy goals
Janssen Pharmaceutical Companies of Johnson & Johnson has stopped the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical…
Janssen Pharmaceutical Companies of Johnson & Johnson has stopped the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical…